Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126377821 | 12637782 | 1 | I | 2015 | 20160226 | 20160809 | 20160809 | PER | US-ABBVIE-16P-163-1570630-00 | ABBVIE | 0.00 | F | Y | 74.00000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126377821 | 12637782 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Unknown | Y | UNKNOWN | 18723 | TABLET | ||||||||
| 126377821 | 12637782 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Intramuscular | UNKNOWN | 0 | 400 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126377821 | 12637782 | 1 | Product used for unknown indication |
| 126377821 | 12637782 | 2 | Bipolar disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126377821 | 12637782 | Alopecia | |
| 126377821 | 12637782 | Diarrhoea | |
| 126377821 | 12637782 | Drug hypersensitivity | |
| 126377821 | 12637782 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126377821 | 12637782 | 1 | 2015 | 0 | ||
| 126377821 | 12637782 | 2 | 201504 | 0 |